The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #36043 · Form 4 · 0001899977-26-000010

ACADIA PHARMACEUTICALS INC · Stock award · Common Stock

ACADIA PHARMACEUTICALS INC · Transacted October 15, 2026 · Filed October 30, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for ACADIA PHARMACEUTICALS INC records a stock award involving Common Stock on October 15, 2026. The reported quantity was 6,815. The filing date is October 30, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001070494
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
6,815
Reported price
0 · See footnotes
Reference value
0
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
74,643
Ownership description
Not reported
SEC acceptance time
Oct 30, 2026, 8:20 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

ACAD · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at incremental 25% of target. Together with the vesting on August 16, 2024 and September 12, 2025, the performance stock units have vested at 100% of target.
F2
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.